Fondazione Telethon

The US Food and Drug Administration takes a “more pragmatic” approach to cell and gene therapy development, which provides companies with a “less stringent pathway” to show that their product has pote

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. OncoSec

The Alliance for Regenerative Medicine held its annual Cell & Gene Meeting on the Mesa in La Jolla, CA, in early October. Over the course of the three-day partnering meeting and scientific symposium

GlaxoSmithKline PLC has become the first big pharma to file for marketing approval of a gene therapy by submitting GSK2696273 for ADA-severe combined immune deficiency in Europe. GSK’s five-year-old